Presented by: TBA
Presentation title: TBA
The conference theme will be “The Opioid Crisis as a Threat to Ending HIV: Multidisciplinary Perspectives on Prevention and Treatment.” More details to come.
Presented by: Charles Clelend, PhD
Presentation title: What is Happening with My Research Project Right Now? Tools for Building and Sharing Dynamic Reports from Web-based Data Collection
Web-based data collection tools such as REDCap provide access to data as it is collected. This talk will show how to retrieve data from databases like REDCap and then build and share dynamic reports of research study progress using R and GitHub. Individuals who manage, plan, or execute research studies, including principal investigators, project directors, data managers, and research assistants, should benefit.
Charles Cleland is a quantitative psychologist and biostatistician with more than ten years of experience in the field of public health research. His methodological interests include longitudinal data analysis, meta-analysis, respondent driven sampling, and multilevel modeling. His substantive research interests include health disparities, particularly in the areas of substance use and infectious disease.
Presented by: Kimberly Page, PhD, MPH, MS
Presentation title: Challenges of HIV and HCV Prevention and Care for PWID in Rural Areas
Dr. Page will discuss the epidemiology of the emergent HCV epidemic in PWID in rural areas, and how it relates to HIV risk. She will talk about some of the successes and challenges of research and practice in providing prevention and care, gaps in information and tools. Discussion will be encouraged!
Kimberly Page, PhD, MPH, MS
Kimberly Page’s research is principally focused on epidemiological studies of HIV and hepatitis C virus (HCV) infections in high-risk populations. She leads multidisciplinary translational studies with an aim towards prevention of these infections and impacting public health. Her work includes prospective observational, implementation, and intervention research. She takes great pride in the trans-disciplinary nature of the work she leads, which includes a diverse group of collaborators including clinicians, social scientists, mathematical modelers, and public health specialists, as well as basic scientists in the fields of immunology and virology. Her research is focused on high risk groups that experience social stigma and associated vulnerability, including people who inject drugs, sex workers, incarcerated populations, low income men and women, and men who have sex with men. Community support has been essential to the success of her research and she works closely with health departments and community based organizations to ensure the public health relevance of her research.
Dr. Page has led some of the most significant and successful research on HCV infection in the U.S. and internationally. Her prospective observational study, known as the UFO Study, has produced data on acute HCV, as well as other blood borne infections and health outcomes including: incidence and risk factors for HCV seroconversion, HIV, mortality, drug-related overdose, gender-related risk, and trends in drug use including the now recognized increase in opiate pill use. Her work with injectors and HCV were significant in her becoming a co-PI on the only HCV vaccine trial ever conducted and still in progress. She opened the San Francisco clinical trial site for this trial, and a new site in Albuquerque, New Mexico. She also led new studies of HCV and HIV in New Mexico in response to emerging epidemics in rural and suburban areas being seen nationwide. She has assembled a large consortium of researchers leading other studies of incident HIV and HCV to form a collaborative with merged data from multiple geographic locations, globally, leading to the largest database on HCV and HIV in injectors globally. The primary site for her HIV research is based in Cambodia, where she implemented an HIV and drug prevention “implementation science” project in 10 provinces throughout the country.
Presented by: Blair T. Johnson, PhD
Presentation title: To be announced
Blair T. Johnson is a Board of Trustees Distinguished Professor in the University of Connecticut’s Department of Psychological Sciences, where he teaches courses related to health psychology, attitude change, and meta-analysis. Johnson has been a prominent scientific methodologist throughout his career; especially in relation to meta-analysis, which he labels “the original big data.” His substantive research has focused on social influence and behavioral health, especially HIV/AIDS, exercise and blood pressure, placebo responding in antidepressants, and most recently, strategies to improve mental and physical health to promote healthy lifestyle choices. He has been awarded numerous grants from the U.S. Public Health Service. Currently, Dr. Johnson is a senior editor with the journal Social Science & Medicine and an Associate Editor of Psychological Bulletin.
Presented by: Lisa Marsch, PhD
Presentation title: Transforming Addiction Treatment via Digital Technology
Description: Advances in digital technologies have created unprecedented opportunities to assess and modify health behavior and health outcomes and thus accelerate the ability of science to contribute to improved health and health care. About 90% of the world’s population subscribes to mobile phone services. Growing evidence indicates that increased access to these technologies is also evident in many traditionally underserved populations and in low and middle income countries. Given the widespread access to technology worldwide, health behavior change tools delivered on mobile platforms enable widespread reach and scalability of evidence-based interventions.
In this presentation, Dr. Marsch will provide an overview of the state of the science on leveraging digital technologies in the treatment of substance use disorders. She will discuss opportunities in the development, evaluation, and sustainable implementation of new models of substance use disorder care that harness empirically-supported digital technologies to extend the reach, impact, personalization and cost-effectiveness of care.
Lisa A. Marsch is the Director of the Dartmouth Center for Technology and Behavioral Health, a designated “Center of Excellence” supported by the National Institute on Drug Abuse at the National Institutes of Health. She is also the Director of the Northeast Node of the National Drug Abuse Clinical Trials Network based out of Dartmouth and the Andrew G. Wallace Professor within the Department of Psychiatry at the Geisel School of Medicine at Dartmouth College. And, she leads a national “Science of Behavior Change” initiative supported by the National Institutes of Health with partners at Dartmouth, Stanford, Arizona State University, Drexel, and MIT.
Dr. Marsch has been Principal Investigator on 26 grants totaling approximately $50 million in grant funding, largely from the National Institutes of Health. She has led the development, evaluation and implementation of technology-based therapeutic tools for addiction treatment, HIV prevention, mental health, chronic pain management, substance abuse prevention, smoking cessation, and obesity. Her work in technology and addiction treatment has been particularly pioneering, as she is widely recognized as having led the development of the most widely tested and evidence-based mobile intervention for addiction treatment.
Presented by: Charles Clelend, PhD
Presentation title: Hands-On Practice with R
Description: This will be an opportunity to walk through data management and analysis exercises in R. The session is designed with the participants of Dr. Cleland’s 2016 Introduction to R in mind (i.e., at least a small amount of prior exposure to R). Participants will work on their own laptops to 1) import & export data; 2) calculate new variables, merge, subset, aggregate, and reshape data; 3) generate descriptive and simple inferential statistics; and 4) produce an analysis report. Participants will be supported to install the required tools (R [www.r-project.org] and RStudio [www.rstudio.com]) on their own laptops before the day of the session.
Registration for this session is closed. If you would like to be placed on the waiting list, please contact us at email@example.com.
Presented by: Genesis Samonte, MD, MSc
Presentation title: A Crystal Ball. A Dark Horse. And the Avengers. The Rapidly Rising HIV Epidemic in the Philippines
Genesis Samonte, MD, MSc, is and epidemiologist ad manager of the National HIV & STI Surveillance and Strategic Information Unit and the Division of Public Health Surveillance, Epidemiology Bureau, Department of Health, Philippines
Dr. Samonte leads the conceptualization, development and dissemination of all strategic information of the health sector (national & local programs and policies, and foreign assisted projects) pertaining to HIV and sexually transmitted infections for the Philippines. In addition, she manages the monitoring and evaluation of the entire health sector response to HIV in the country, and contributes to the monitoring and evaluation of the country HIV response led by the Philippine National AIDS Council (PNAC).
Sponsored by: NYU College of Global Public Health, Department of Epidemiology, the Center for Drug Use and HIV Research, and the Delta Omega Honorary Society.
Presented by: Donna Coffman, PhD
Presentation title: Practical Methods for Causal Inference with Applications to HIV Research
Description: This presentation will discuss the motivation for and utility of propensity score methods with applications to HIV data. Because random assignment is frequently not possible or participants may not comply with random assignment, propensity scores are an alternative approach to inferring causality. Propensity scores will be defined, followed by how to estimate and apply them. Although there are advantages to using propensity scores, their use does invoke assumptions. These assumptions will be discussed, as well as sensitivity analyses for assessing the implications of violations of assumptions. Issues of non-compliance/non-adherence and assessing mediation will also be discussed.
Dr. Donna Coffman is Assistant Professor in the Department of Epidemiology and Biostatistics in the College of Public Health at Temple University. Her research focuses on causal inference for observational data, especially for assessing mediation and moderation. She currently has a Big Data to Knowledge early career award from the National Institutes of Health to develop and apply data analytic methods to the study of health behavior change using mobile devices.
Presented by: Denis Nash, PhD, MPH
Presentation title: A Global Analysis of the Expansion of HIV Treatment Guidelines, and Research Priorities for ‘Treat-all’ Implementation in sub-Saharan Africa
Denis Nash has over 20 years of expertise in implementation science, and his research consistently generates new knowledge with clear programmatic and policy implications. His experience includes extensive domestic and international work in implementation science, comparative effectiveness research and large-scale epidemiologic studies examining key outcomes among persons with HIV.
Dr. Nash brings seasoned expertise in study design and methodological approaches to large-scale, ‘real-world’, research projects. Prior to joining CUNY, Dr. Nash was an EIS Officer and subsequently the Director of HIV/AIDS Surveillance, where he pioneered named reporting for HIV. He also worked at ICAP at Columbia University as the Director of Monitoring, Evaluation and Research, spearheading a multi-country initiative collecting routine medical records electronically.
Dr. Nash has extensive global health implementation and research experience. He has worked extensively on large scale initiatives and research projects in sub-Saharan Africa, including on the Guinea Worm Eradication Program in Nigeria, sentinel HIV surveillance in Nigeria and Botswana, and rapid expansion/scale-up of HIV/AIDS care and treatment under the President’s Emergency Plan for AIDS Relief (PEPFAR) in Burundi, Cote d’Ivoire, Ethiopia, Kenya, Lesotho, Mozambique, Nigeria, Rwanda, South Africa, Swaziland, Tanzania, Uganda, and Zambia. He has recently begun a research project on non-communicable diseases, which includes household population health survey of 4 urban slums in Port au Prince, Haiti.
Presented by: Benny Kottiri, PhD
Presentation title: HIV/AIDS Research Program at USAID and Funding Opportunities
Benny Kottiri is Chief of the Research Division in the Office of HIV and AIDS at USAID Washington. In this capacity he provides technical and programmatic oversight to a research portfolio that covers HIV vaccines, microbicides, HIV therapeutics, and implementation science under the President’s Emergency Plan for AIDS Relief (PEPFAR). Dr. Kottiri has over 30 years of experience in epidemiological and biomedical research and global health program implementation. Prior to joining USAID, Dr. Kottiri served as Research Epidemiologist at the Centers for Disease Control and Prevention (CDC), where he managed the infectious diseases components of the National Health and Nutrition Examination Survey (NHANES).
Presented by: Charles Clelend, PhD
Presentation title: An Introduction to Research Electronic Data Capture (REDCap) for Data Collection and Research Project Management
Brief Description: REDCap is a widely used secure web application for building and managing online surveys and databases, supporting online and offline data capture and other aspects of research project management. This introduction to REDCap will demonstrate some of its major features and describe its advantages and limitations.
Charles Cleland, PhD, is a quantitative psychologist and biostatistician with more than ten years of experience in the field of public health research. His methodological interests include longitudinal data analysis, meta-analysis, respondent driven sampling, and multilevel modeling. His substantive research interests include health disparities, particularly in the areas of substance use and infectious disease.
Presented by: Samuel Friedman, Carl Latkin, Danielle German, April Young
Presentation title: Social Networks Symposium
This symposium will highlight the costs and advantages of gathering different kinds of social network data as well as showing what it can be used for, making social network research more accessible to researchers.
Introduction to Social Networks for Public Health: Different kinds of networks, different research needs, different kinds of data, different methods, different analyses, different capabilities—and why we care
Samuel Friedman, PhD
National Development and Research Institutes, Inc.
Associate Director, Infectious Disease Epidemiology & Theory Core, CDUHR
Social Network Approaches to Preventing HIV and STIs, Among People Who Use Drugs and Among MSM
Carl Latkin, PhD
Johns Hopkins University
Social Network Approaches in Behavioral and Epidemiological Research: Making Connections Between Social Risk, Recruitment, and Transmission Networks
Danielle German, PhD, MPH
Johns Hopkins University
Connecting the Dots: Methods for Collecting and Constructing Network Data from PWUD
April Young, PhD, MPH
University of Kentucky College of Public Health
Presented by: Arthur Caplan, PhD
Presentation title: Expanded Access, Ethics and Compassionate Use - From Drugs for HIV to Personalized Medicine
Arthur Caplan is the Drs. William F and Virginia Connolly Mitty Professor and founding head of the Division of Bioethics at New York University Langone Medical Center. He is the co-founder and Dean of Research of the NYU Sports and Society Program and the head of the ethics program in the Global Institute for Public Health at NYU.
Dr. Caplan is the author or editor of thirty-five books and over 700 papers in peer reviewed journals. He is a regular commentator on bioethics and health care issues for WebMD/Medscape, for WGBH radio in Boston and WMNF public radio in Tampa. He appears frequently as a guest and commentator on various other national and international media outlets.
Dr. Caplan is the recipient of many awards and honors including:
- McGovern Medal of the American Medical Writers Association
- Franklin Award from the City of Philadelphia
- In 2001, Person of the Year, USA Today
- In 2008, one of the ten most influential people in science by Discover magazine
- One of the fifty most influential people in American health care by Modern Health Care magazine
- One of the ten most influential people in America in biotechnology by the National Journal
- One of the ten most influential people in the ethics of biotechnology by the editors of Nature Biotechnology
- One of the 100 most influential people in biotechnology by Scientific American magazine
- In 2011, Patricia Price Browne Prize in Biomedical Ethics
- In 2014, the Public Service Award from the National Science Foundation/National Science Board, which honors individuals and groups that have made substantial contributions to increasing public understanding of science and engineering in the United States
- In 2016, the National Organization for Rare Disorders (NORD) honored him with their ‘Rare Impact Award’
Presented by: Dita Broz, PhD, MPH
Presentation title: Large Community Outbreak of HIV-1 Infection Linked to Injection Drug Use of Oxymorphone - Indiana, 2015
Dita Broz, PhD, MPH, is an Epidemiologist and Activity Lead for Methods with the Division of HIV/AIDS Prevention, US Centers for Disease Control and Prevention (CDC). In this position, Dr. Broz provides scientific oversight for the implementation of the National HIV Behavioral Surveillance system. Dr. Broz also serves as the subject-matter expert for HIV prevention among persons who inject drugs and supports her Division’s opioid epidemic response efforts. Prior to this position, Dr. Broz served in CDC’s Epidemic Intelligence Service in the Division of Global HIV/AIDS, where she provided technical guidance for conducting HIV surveillance in Kenya, Tanzania and Ethiopia. Dr. Broz completed her PhD in epidemiology from the University of Illinois at Chicago, where she worked on a prospective cohort study of transitions from non-injecting heroin use to drug injection and the risk of HIV and hepatitis B and C transmission.
Presented by: Deborah Padgett, PhD, MPH
Presentation title: Qualitative and Mixed Methods in Implementation Science: Finding the Right Balance
Qualitative methods have been integral to implementation science yet their adaptation for use either alone or within mixed methods designs has been given little attention. This talk will report on the results of a national expert panel convened by NIH/NCI in which the contributions of rigorous qualitative methods are presented as critical to the success of implementation research.
Deborah Padgett, PhD, MPH
Deborah Padgett is internationally known for her mentorship and advocacy of qualitative and mixed methods in research. She is the editor of The Qualitative Research Experience (2004), author of Qualitative Methods in Social Work Research (2016, 3rd ed.) and Qualitative and Mixed Methods in Public Health (2012).
Dr. Padgett has been principal investigator of two R01 qualitative methods studies funded by NIMH. The first, The New York Services Study (2004-2008), was a study of service engagement among dual diagnosed homeless adults in New York City. The second, The New York Recovery Study (2010-2015) used ethnographic methods to examine the role of housing in mental health recovery among formerly homeless adults. Her recent ethnographic research on homeless ‘pavement dwellers’ in Delhi, India is an extension of this interest in homelessness to cross-cultural contexts.
Dr. Padgett received the NYU Distinguished Teaching Award (2012) and was Director of the PhD program in Global Public Health (2014-2016). She was named a Fellow of the American Academy of Social Work and Social Welfare (AASWSW) in 2011 and a Fellow of the Society for Social Work and Research (SSWR) in 2013. She has been active in SSWR since its inception and served as a board member (2002-2007) and President (2004-2006). In 2006, SSWR announced the Deborah K. Padgett Early Career Fellowship in recognition of her contributions.